name - ariel.ac.il€¦ · web view1994-1996 research associate (post-doctorate) on mrc grant...

Name Aviv Malkiel Weinstein (Ph.D) Date May 2014

CURRICULUM VITAE AND LIST OF PUBLICATIONS

Personal Details

Name Aviv Malkiel Weinstein

Date of birth 1st April 1961 Place of Birth- Haifa Israel

Permanent Home Address: 8 Yefe Noff Street Zikhron Yaaqov, Israel.

Regular military service August 1979- September 1982

Home Telephone Number: 046399151 046397680

Cellular Phone: 972-524307610

Fax Number: 972-46397680

Work address: Dept. of Behavioral Sciences, University of Ariel, Ariel 40700.

Electronic Address: [email protected]

Education

B.Sc Years 1988-1991- Hull University UK, Dept. of Psychology

Ph.D Years 1991-1994 University of Bristol, UK Dept. of PsychologyName of advisor- Prof. David.J.Nutt Title of thesis “Cognitive dysfunction in anxiety

disorders ”

Employment HistoryCurrent position- Temporary Senior Lecturer: Dept. of Behavioral Sciences, University of

Ariel

2011- 2013 Adjuvant Lecturer Dept. of Social work Tel Hai academic college.

2005-now Senior Research Fellow Dept. of Medical biophysics and Nuclear Medicine, Hadassah

Ein Kerem, Jerusalem.

2003-now Senior Research Fellow, Dept. of Nuclear Medicine, Sourasky Medical Center,

Weizman 6, Tel Aviv 64239.

2000-2007 Special Lecturer within community based Medicine, Faculty of Medicine and

Dentistry, University of Bristol, University Walk, Bristol BS8 1TH, UK

1998-1999 Research Fellow, Brain Imaging Centre, IRP NIDA/NIH, Johns Hopkins Bayview,

5500 Nathan Shock Drive, Baltimore MD 21224.

1996-1998 Lecturer, School of Psychology, University College of North Wales,

Bangor, Gwynedd LL57 2DG, UK and Psychopharmacology Unit, School of Medical

Sciences, University of Bristol, Bristol BS8 1TD, UK.

mailto:[email protected]

Name Aviv Weinstein (Ph.D) page

1994-1996 Research associate (post-doctorate) on MRC grant investigating cognitive

neuropsychological mechanisms of drug craving in opiate addicts, Psychopharmacology

Unit, School of Medical Sciences, University of Bristol, UK.

1993-1994 Research assistant on Medical Research Council (MRC) grant investigating

attention mechanisms in Parkinson’s disease including brain's electrophysiology,

Perception System Research Centre, Psychology Department, University of Bristol, UK.

1991-1993 Ph.D. student, Psychology Department and the Psychopharmacology Unit,

School of Medical Sciences, University of Bristol, UK. Self-funded.

1988-91 Student, Psychology (B.Sc.) Hull University, UK .

1986-8 Student, Danish, Language School Copenhagen University, Denmark. Worked

voluntarily in the rehabilitation of drug addicts .

1982-6 Student, Law and Philosophy (B.A). Tel-Aviv University, Israel

1979-82 Military Service in the Israeli defence forces.

Professional Activities (in reverse chronological order)

(a) Positions in academic administration (departmental, faculty and university)

1996-1998 Lecturer University of Wales in Bangor Wales UK Department of

Psychology

2000-2002 Senior Lecturer University of Bristol, Bristol UK Department of Psychiatry and Mental Health(b) Editor or member of editorial board of scientific or professional journal

1) Spanish Journal of Addiction (Trastornos Addictivos) since 2000.

2) The Journal of Groups in Addictions and Recovery since 2003.

3) Frontiers in Impulsivity, Compulsivity and Behavioral Dyscontrol since 2010.

4) The Journal of Behavioral Addictions since 2011.

5) Current Addiction Reports since 2014.

6) Journal of substance abuse and alcoholism since 2014.

(d) Membership in professional/scientific societies

Member of the British Association for Psychopharmacology since 1995, a regular member

of the College of Problems of Drug Dependence (CPDD) since 2004 and World Federation

of Societies for Biological Psychiatry since 2006.

Educational activities

Courses taught

2013-Now- Developmental Psychology and Physiological Psychology- courses for 1st year

students, Psychopathology and a seminar on Behavioral Addictions, courses for 3rd year

students Dept. of Behavioral Sciences, University of Ariel.


2011-2013 Neuropsychology, Neuropsychiatry, Psychopathology, Developmental

Psychology courses for 1st and 3rd year students Social work and interdisciplinary studies,

Tel Hai Academic College

1998-MSc in addiction, Psychology Department, University of Wales, College of

Swansea, UK.

1996-1998- “Stress anxiety and coping” course and “drug addiction” as part of the

‘Abnormal Psychology’ course for undergraduates in the School of Psychology,

University of Wales, Bangor, UK.

1992-1998- Behavioural science course for medical students, Tutor, School of

Medical sciences and on the undergraduate course in Psychology in the

(b) Research students

1997 Barbara Feldtkeller M.Sc Psychology Department, University of Bristol, UK.

Joint supervision with Prof. Nutt

Awards, Citations, Honors, Fellowships

(a) Honors, Citation Awards (including during studies)

Year - granting institution - name of award

Scholarship for Ph.D.Bristol University, UK

1991-1994

Post-doctorate fellowship.Medical Research Council, UK

1994-1996

Visiting Research Fellow.National Institute on Drug Abuse (NIDA)/University of California at Los Angeles (UCLA) USA

1998-2000

Israeli anti-drug authority travelling fellowship award.

National Institute on Drug Abuse (NIDA)/College on Problems of Drug Dependence (CPDD)

2003

International travelling fellowship award.

World Health Organization (WHO)/NIDA/CPDD

2004

(b) Fellowships (e.g. Fullbright)

1998-1999 Visiting Research Fellow, Brain Imaging Centre, Intramural Research Program

National Institute on Drug Abuse (NIDA) National Institute of Health (NIH), Johns

Hopkins Hospital Bayview, 5500 Nathan Shock Drive, Baltimore MD 21224 USA

($36,000 every year).


Scientific Publications

1. Weinstein, A.M. (1995). Visual ERPs Evidence for Enhanced Processing of Threatening

Information in Anxious University Students. Biological Psychiatry, 37 (12), 847-858. Impact

Factor: 8.926.

2. Weinstein, A.M., Nutt, D.J. (1995) A cognitive dysfunction in anxiety and its amelioration by

effective treatment with SSRIs. Journal of Psychopharmacology, 9 (2), 83-89. Impact Factor:

3.37.

3. Weinstein, A.M., Wilson, S., Bailey, J., Nutt, D.J. (1996). Sedative antidepressants impair

visual detection mechanisms in humans. Journal of Psychopharmacology, 10(2), 141-145.

Impact Factor: 3.37.

4. Weinstein, A.M., Neal, L., Lillywhite, A., Potokar, J., Nutt, D.J. (1996). Cognitive processing

in PTSD. Anxiety Disorders, 2, 130-139. Impact Factor: 2.682.

5. Weinstein, A.M., Troscianko, T., and Calvert, J. (1997). Impaired Visual search Mechanisms

in Parkinson's Disease: An Event-Related Potentials Study. Journal of Psychophysiology, 11, 33-

47. Impact Factor: 2.488.

6. Weinstein, A.M., Wilson, S., Bailey, J.E., Myles, J. Nutt, D.J. (1997). Imagery of craving in

opiate addicts undergoing detoxification. Drug and Alcohol Dependence, 48, 25-31. Impact

factor 3.599.

7. Weinstein, A.M., Lingford-Hughes, A., Martinez-Raga, J., Marshall, J. (1998). What makes

alcohol-dependent individuals early in abstinence crave for alcohol: exposure to the drink, images

of drinking or remembrance of drinks past? Alcoholism: Clinical and Experimental Research, 22

(6), 1376-1381. Impact Factor: 3.421.

8. Weinstein, A.M., Feldtkeller, B., Malizia, A., Wilson, S., Bailey, J.E., Nutt, D. (1998).

Integrating the cognitive and physiological aspects of craving. Journal of Psychopharmacology,

12(1), 31-38. Impact Factor: 3.37.

9. London, E.D., Ernst, M., Grant, S., Bonson, C., Weinstein, A.M. (2000). Orbitofrontal Cortex

and Human Drug Abuse: Functional Imaging. Cerebral Cortex, 10, 334-342. Impact Factor:

6.979.

10. Weinstein, A.M., Feldtkeller, B., Law, F., Myles, J., Nutt, D.J. (2000). The processing of

automatic thoughts of drug use and craving in opiate dependent subjects. Experimental and

Clinical Psychopharmacology, 8(4), 549-553. Impact Factor: 2.545.

11. Feldtkeller, B., Weinstein, A.M., Cox, W.M., Nutt. D.J. (2001). Effects of Contextual

Priming on Alcohol-Related Lexical Decisions in Alcohol-Dependent and non-dependent

Participants. Experimental and Clinical Psychopharmacology, 9 (3), 343-351. Impact Factor:

2.545.


12. Daglish, M.R.C., Weinstein, A., Malizia, A.L., Wilson, S., Melichar, J.K., Britten, S., Brewer,

C., Lingford-Hughes, A., Myles, J., Grasby, P., Nutt, D.J. (2001). Changes in Regional cerebral

blood flow elicited by craving memories in abstinent opiate-dependent subjects. American

Journal of Psychiatry, 158, (10), 1680-1686. Impact Factor: 14.72.

13. Wilson, S.J., Bailey, J.E., Alford, C., Weinstein, A., Nutt, D.J. (2002). Effects of 5 weeks

administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation,

psychomotor performance and mood. Journal of Psychopharmacology, 16, (4), 321-331. Impact

Factor: 3.37.

14. Weinstein, A.M., Feldtkeller, B., Feeney, A., Lingford-Hughes, A., Nutt. D.J. (2003). Effects

of treatment with acamprosate on craving for alcohol in Alcohol-Dependent Patients. Addiction

Biology, 8, 229-231. Impact Factor: 4.728.

15. Daglish, M.R.C, Weinstein, A.M., Malizia, A.L., Wilson, S., Melichar, J.K., Lingford-

Hughes, A., Myles, J.S., Grasby, P., Nutt, D.J. (2003). Functional connectivity analysis of the

neural circuits of opiate craving- “more” rather than “different”? Neuroimage, 20, 1964-1970.


16. Weinstein, A., Cox, W., Miles. (2006). Cognitive processing of drug-related stimuli: the role

of memory and attention. Journal of Psychopharmacology, 20 (6), 850-859. Impact Factor:

3.37.

17. Zetteler, J.I., Stollery, B.T., Weinstein, A.M., Lingford-Hughes, A.R. (2006). Attentional bias

for alcohol-related information in adolescents with alcohol-dependent parents. Alcohol and

Alcoholism, 41(4):426-430. Impact Factor: 2.68.

18. Weinstein, A., Brickner, O., Lerman, H., Greemland, M., Bloch, M., Lester, H., Freedman,

N., Mechoulam, R., Bar-Hamburger, R., Chisin, R., Even-Sapir, E. (2007). Brain imaging study

of the acute effects of Δ-9 THC on attention and motor coordination in regular users of

marijuana. Psychopharmacology 196(1): 119-131. Impact Factor: 4.06.

19. Karila, L., Gorelick, D.A., Weinstein, A., Noble, F., Benyamina, A., Blecha, L., Coscas, S.,

Gillaizeau, I., Lowenstein, W., Lépine, J.P,.Reynaud, M. (2008). New treatments for cocaine

dependence: a focused review. International Journal of Neuropsychopharmacology, 11 (3), 425-

438. Impact Factor: 5.64.

20. Karila, L., Weinstein, A., Benyamina, A., Coscas, S., Leroy, C., Guillard, K., Noble, F.,

Lowenstein, W., Lépine, J.P., Reynaud, M. (2008). Options pharmacologiques actuelles dans la

dépendance à la cocaïne - Current pharmacological options in the treatment of cocaine

dependence. Presse Med 37 (4 Pt 2):689-98 (in French). Impact Factor: 0.867.

21. Weinstein, A., Brickner, O., Lerman, H., Greemland, M., Bloch, M., Lester, H., Chisin, R.,

Sarne, Y., Mechoulam, R., Bar-Hamburger, R., Freedman, N., Even-Sapir, E. (2008). A study


investigating the acute dose-response effects of 13mg and 17mg Δ 9-THC on cognitive-motor

skills, subjective and autonomic measures in regular users of marijuana. Journal of

Psychopharmacology, 22(4), 323-333. Impact Factor: 3.37.

22. Weinstein, A., Yemini, Z., Greif, J. (2008). Cigarette smoking cessation treatment combining

group therapy with Zyban. Journal of Groups in Addiction and Recovery, 3(1), 21-29.

23. Weinstein, A., Greif, J., Yemini, Z., Lerman, H., Weizman, A., Even-Sapir, E. (2010).

Attenuation of cue-induced smoking urges and brain reward activity in successfully-treated

smokers with bupropion. Journal of Psychopharmacology, 24, 829-838. Impact Factor: 3.37.

24. Karila, L., A., Weinstein, A., Noble, F., Benyamina, A., Blecha, L., Lépine, J.P,.Reynaud, M.

(2010). New treatments for methamphetamine dependence: a focused review. British Journal of

Clinical Pharmacology, 69(6):578-92. Impact Factor: 3.58.

25. Weinstein, A (2010). Computer and video game addiction. American Journal of Drug and

Alcohol Abuse, 36(5), 268-276. Impact Factor: 1.335.

26. Weinstein, A., Lejoyeux, M. (2010). Internet addiction or Excessive Internet Use. American

Journal of Drug and Alcohol Abuse, 36(5), 277-283. Impact Factor: 1.335.

27. Lejoyeux, M., Weinstein, A. (2010). Compulsive buying. American Journal of Drug and

Alcohol Abuse, 36 (5), 248–253. Impact Factor: 1.335.

28. Grant, J.E., Potenza, M.N., Weinstein, A., Gorelick, D.A (2010). Introduction to Behavioral

Addictions. American Journal of Drug and Alcohol Abuse, 36(5), 233–241. Impact Factor:

1.335.

29. Weinstein, A., Miller, H., Tal, E., Ben Avi, I., Herman, I., Bar-Hamburger, R., Bloch, M.

(2010). Treatment of Cannabis Withdrawal Syndrome using Cognitive-behavior therapy and

relapse prevention for cannabis dependence. Journal of Groups in Addiction and Recovery, 5(3-

4) 240-264.

30. Weinstein, A.M., Gorelick, D.A. (2011). Pharmacological treatment for cannabis dependence.

Current Pharmaceuticals Design, 17(14):1351-8. Impact Factor: 4.39

31. Weinstein, A.M., Weizman, A. (2012). A. Emerging Association between Addictive Gaming

and Attention-Deficit/Hyperactivity Disorder. Current Psychiatry Reports, 14 (5), 590-597.

Impact Factor: 3.23

32.Weinstein, A.M., Lejoyeux. (2013). New developments in the psychobiology of

internet and videogame addiction. American Journal of Addiction, 20, 1-9. Impact

Factor: 1.74.

33. Lejoyeux, M., Weinstein, A. (2013). Shopping Addiction in Principles of Addiction

Volume 1, Chapter 85, pp 1-7, Elsevier.


34. Peles, E., Weinstein, A., Schreiber, S., Sason, A., Adelson, M. (2013). An interaction

in the Stroop interference effect among patients with obsessive compulsive disorder (OCD)

and patients with attention deficit hyperactivity disorder (ADHD) in methadone

maintenance treatment (MMT). Journal of Central Nervous Disease. Impact Factor: 3.409

35. Weinstein, A. (2013). Internet and Videogame Addiction: Clinical Implications

for Assessment and Treatment. CME lesson- Directions in Psychiatry," Volume 33,

Part 2.

Lectures and Presentations at Meetings and Invited Seminars not followed by

Published Proceedings

Presentation of papers at conferences/meetings (oral or poster)

Role

Subject of Conference/Role at Conference/Comments

Place ofConference

Name ofConference

Date

Presenter Oral

Drug DependenceSan Juan Puerto Rico

College of Problems of Drug Dependence

1996

PresenterDrug DependenceScottsdale Arizona

USA


1999

PresenterNeuropsychopharmacology

Puerto RicoAmerican College of Neuropsychopharmacology

1999

PresenterDrug DependenceFlorida USACollege of Problems of Drug Dependence

2003

PresenterDrug DependenceSan Juan Puerto Rico


2004

PresenterDrug DependenceOrlando Florida


2005

PresenterDrug DependenceScottsdale Arizona

USA


2006


Paris FranceEuropean College of Neuropsychopharmacology

2006

PresenterDrug DependenceQuebec Canada


2007


Vienna Austria

European College of Neuropsychopharmacology

2007

Presenter and chair of symposia on

cocaine addiction

PsychiatryNice, FranceAssociation of European Psychiatrists

2008


Barcelona, Spain

European College of Neuropsychopharmacology

2008

Presenter and chair of symposia on

brain

Biological PsychiatryParis FranceWorld Federation Societies of Biological Psychiatry

2009


imaging in drug

addiction and

behavioral addictionPresenter

and Chair of symposia on

cannabis addiction

PsychiatryNew Orleans USA

American Psychiatric Association

2010

Presenter and Chair on symposia on

brain imaging in addiction

and cannabis

Biological PsychiatryPrague, Czech

Republic

World Federation Societies of Biological Psychiatry

2011

Presenter in symposia on

brain imaging of

nicotine and cannabis

Drug DependenceHollywood Florida USA


2011

Invited plenary

speaker on internet

addiction and the brain

Behavioral addictionsBudapest, Hungary

International Congress on behavioral addictions

2013

Chair symposium on cannabis

Biological PsychiatryKyoto JapanWorld Federation of Biological Psychiatry 11th

meeting

2013

And presenter on behavioral addiction

PsychiatryBarcelona Spain

Dual diagnosis conference2013

PresenterDrug dependenceSan Juan Puerto Rico


2014

(d) Seminar presentations at universities and institutions

Presentation/Comments

Name of ForumPlace of LectureDate

Cognitive Mechanisms in Drug Dependence

National Institute on Drug Abuse

and National Institute on Health

NIDA/NIH

Johns Hopkins Bayview Hospital, Baltimore, MD

USA

1997

Brain imaging in Drug Dependence

National Institute on Drug Abuse

and National Institute on Health

NIDA/NIH

Johns Hopkins Bayview Hospital, Baltimore, MD

USA

2010


Research Grants

AmountYearFunded byTopicCo-ResearchersRole in Research

40,000£.1993-4Medical Reseach

Council (MRC) UK

Attentional Mechanisms in

Parkinson’s Disease

Dr. Tom Troscianko Dr. June Calvert

Co-PI

£40,000.1994-5Medical Reseach

Council (MRC) UK

Cognitive processing in opiate addicts.

Prof. David Nutt and Dr. Judy Myles

Co-PI

£30,000.

1995-6Medical Reseach

Council (MRC) UK

Cognitive processing in

alcohol addiction.

Prof. David Nutt, Dr. Barry Jones, Dr. John

McMahon

Co-PI

£40,000.1996-7British Economic and Social

Research Council

Cognitive processing in

alcohol addiction.

Prof. B. Jones, Prof. W. M. Cox, Dr. J. Mc Mahon

Co-PI

£40,000.1996-7South West Regional Health Authority, UK

Cognitive- behavior

treatment of opiate-dependent

individuals

Prof. David Nutt, Dr. Judy Myles

Co-PI

£50,000.1996-8Merck-Lipha pharmaceuticals

Craving for alcohol and its treatment by acamprosate

Prof. David NuttCo-PI

$10,0002003-4“Adams Trust” Tel Aviv

University, Israel.

Functional brain imaging in

recreational users of “Ecstasy”

(MDMA).

Prof. Einat Even-SapirCo-PI

$80,0002004-6Chief Scientist, Ministry of

Health, Israel.

Brain imaging study into the

effects of abstinence and

craving in heavy and light cigarette

smokers.


$30,0002004-5Israeli Anti-Drug Authority,

Jerusalem, Israel.

Brain Imaging study of

orientation, coordination and

executive function in recreational

users of marijuana.


$30,0002005-8Israeli Anti-Drug Authority,

Jerusalem, Israel.

Functional brain imaging in

recreational users of “Ecstasy”

(MDMA).

Prof. Yodphat KrauszCo-PI

$90,0002005-2011

The National Institute for

Psychobiology in Israel.

A pharmaco-genetic and brain imaging study of dopamine release

in drug abuse

Prof. Roland Chisin, Prof. Avi Weizman, Prof.

Richard Ebstein

PI


$470,0002006-2010

Sacta-Rashi Foundation.

The effects of modafinil and topiramate on

brain mechanisms underlying cue-induced cocaine

craving and dependence in

methadone maintained

cocaine dependent patients.

Prof. Roland Chisin, Prof. Henri Atlan

Co-PI

$50,0002007-2009

Israeli Anti- Drug Authority.

Treatment of Marijuana

Withdrawal Syndrome Using Escitalopram in

Combination with Cognitive-

behavior therapy

Dr. Miki BlochCo-PI

$75,0002011-Now

Israeli Anti-Drug Authority,

Jerusalem, Israel.

Evaluation of the effects of psychological and pharmacological treatment of "backpackers" in Kfar Izun in Israel

Prof. Einat Even-SapirPI

• Synopsis of research, including reference to publications and grants in above lists (Do not

exceed three single-spaced pages.)

Over the past 20 years, I have developed expertise in psychological,

pharmacological and brain imaging aspects of theory and treatment of drug and

alcohol dependence. First, I have investigated the psychological processes that

are responsible for craving and withdrawal in opiate and alcohol-dependent

patients, including a study on brain imaging of craving for opiates in Positron

Emission Tomography (PET) in Bristol and London, UK. This work was a new

cognitive-physiological-brain approach to drug craving and dependence which

resulted in several grants and prestigious publications.

I was then trained in brain imaging in PET in NIDA, in Johns Hopkins,

Baltimore USA which added an expertise in brain imaging in addiction. My

work included training in PET brain imaging in Baltimore and establishment of

a brain imaging facility in UCLA together with Prof. Edythe London. This

resulted in several publication and grants and international expertise in brain

imaging in the field of drug and alcohol addiction.

Thirdly, I have specialized in combined pharmacological and psychological

treatment for opiate and alcohol dependence in the UK and the US.


These three aspects of addiction namely- theoretical models, brain imaging and

treatment have been further developed in Israel. I have first established a brain-

imaging laboratory (PET/SPECT) in the Dept. of Nuclear Medicine in Sourasky

Medical Centre in Tel Aviv (2004-now) and then in Hadassah Medical

Organization in Jerusalem Israel (2006-now). We have conducted studies on the

effects of “ecstasy” and marijuana on the cognitive, motor function and brain

activity in recreational users (see grants 2004-2007). We have further

conducted several studies on combined pharmacological-psychological

treatment of nicotine, cocaine and cannabis dependence (see grants 2006-2011).

Further work on pharmacological and psychological treatment of drug and

alcohol addiction includes studying the effects of pharmacological and

psychological treatment of psycho-stimulant dependence on the brain (Israeli

Anti-Drug Authority 2012-now).

I am particularly interested in the combination of molecular genetics and brain

imaging which is an exciting new field of research. It has major scientific

implications for understanding of drug dependence. Furthermore, this research

is aimed to answer important clinical questions such as who is likely to develop

cannabis-induced psychosis and who is likely to benefit from the various

pharmacological treatments for cannabis and nicotine-dependence. We started a

collaboration with Prof. Edythe London from UCLA on brain imaging of

dopamine in synthetic drug users. We have also started collaboration with Dr.

Tami Kushnir the Head of the fMRI unit in Tel Hashomer hospital for research

on cannabis and synthetic drugs. Finally, we have published several papers and

reviews on behavioural addiction (I am on the Editorial board of the Journal of

Behavioral addictions and the scientific committee of the journal and

international meeting). I plan to expand this work into internet addiction, eating

disorders, sports and sex addiction with collaborators in Israel and abroad.

• Present Academic Activities

Research in progress

Evaluation of the effects of psychological and pharmacological treatment of

"backpackers" in Kfar Izun in Israel with Prof. Einat Even-Sapir (Sourasky)

Omri Frisch (Kfar Izun). $83,000. Expected date of completion October 2014

• Additional Information


My teaching experience includes teaching courses on behavioural science to

medical students at the University of Bristol, Abnormal Psychology (B.Sc) and addiction

(M.Sc) University of Wales, and Neuropsychology, Neuropsychiatry, Psychopathology

and Developmental Psychology (B.A) Social work and interdisciplinary studies, Tel Hai

Academic College and Developmental Psychology and behavioral addiction in the

University of Ariel. I have jointly supervised undergraduate students and an M.A student

in Psychology in Bristol UK. My professional activity included being a member of

editorial boards of the Spanish Journal of Addiction (Trastornos Addictivos) since 2000,

The Journal of Groups in Addictions and Recovery since 2003, Frontiers in Impulsivity,

Compulsivity and Behavioral Dyscontrol since 2010, The Journal of Behavioral

Addictions since 2011. I am also a member of the British Association for

Psychopharmacology since 1995, a regular member of the College of Problems of Drug

Dependence (CPDD) since 2004 and Israeli and World Federation of Societies for

Biological Psychiatry since 2006. My work has received international recognition and I

have participated and presented in 20 international conferences. In recent years I have been

co-chairperson in symposia on brain imaging in addiction and cannabis addiction in

international meetings such as the World Federation of Biological Psychiatry (2009, 2011,

2013) and the American College of Psychiatry (2010).

Since my arrival at the University of Ariel, I have taught the courses on Physiological

Psychology, Developmental Psychology, Psychopathology and behavioral addiction. In the

next academic year I will supervise 3 M.A students on projects on behavioural addictions

and an M.A students jointly with Dr. Zsolt Demtorovics the head of the Institute of

Psychology at Eötvös Loránd University in Budapest in Hungary on synthetic drugs. In

view of new programs for research, I intend to contribute my expertise in preparing new

syllabus and teaching in the University of Ariel.

Articles in press

36. Weinstein, A.M., Feder, K., Rosenberg, K., Dannon, P (2014). Internet

addiction- criteria evidence and treatment. Chapter 5 in a book titled “Behavioral

Addictions: Criteria, Evidence and Treatment” Elsevier.

37. Weinstein, A.M., Miller, H., Bluvstein, I., Tal, E., Rapaport, Y., Schreiber, S.,

Bar-Hamburger, R, Bloch, M. Treatment of Marijuana Withdrawal Syndrome

Using Escitalopram in Combination with Cognitive-behavior therapy: a Double-

Blind Placebo-Controlled Study. American Journal of Drug and Alcohol Abuse.



38. Weinstein, A.M., Weinstein I. (2014). Sports addiction- a review in a special edition

titled “New behaviors, New drugs: the modern landscape of addiction” by Current

Pharmaceutical Design. Impact Factor: 4.39

39. Karila, L., Wéry, A., Weinstein, A., Cottencin, O., Reynaud, M., Billieux, J.

(2014). Sexual addiction or hypersexual disorder: Different terms for the same

problem? A review of the literature. A chapter for a special edition named “New behaviors, New drugs: the modern landscape of addiction” by Current Pharmaceutical Design. Impact Factor: 4.39.

40. Weinstein, A., Dinur, L., Dannon, P (2014). A Comparison of the Status, Legal,

Economic, and Psychological Characteristics of Types of Adult Male Gamblers.

Journal of Gambling studies.

Books and articles in preparation to be published

1. Weinstein, A Aboujaoude, E. Internet addiction a chapter in the book titled: “Mental

Health in the Digital Age: Grave Dangers, Great Promise”. Editors: Elias Aboujaoude and

Vladan Starcevic. Oxford University Press.

2. Weinstein and Weinstein I. A chapter on Sports Addiction in a book titled:

Behavioral Addictions. Editor Nancy Petry. Oxford University Press.

3. Weinstein, A., Freedman, N., Greif, J., Mishani, E., London, E.D., Chisin, R.,

Bocher, M. A brain-imaging study of nicotine-induced dopamine release in

cigarette smokers in treatment with bupropion using [11C] raclopride in positron

emission tomography. Was presented in CPDD 2011.

4. Weinstein, A.M., Freedman, N., Herman, I., Mishani, E., Gorelick, D.A., Atlan, H., Chisin, R. The effects of modafinil and topiramate on brain mechanisms underlying

cue-induced cocaine craving and dependence in cocaine and heroin dependent patients

(Will be presented in CPDD 2014.

name - ariel.ac.il€¦ · web view1994-1996 research associate (post-doctorate) on mrc grant...

Documents